ArticleBlood cancer journal2026

A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma.

Ricardo Ahrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.